+ Watch NPSP
on My Watchlist
A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins.
A major drug for short bowel syndrome. Although there are only about 15,000 patients in the US with this affliction-revenue production will be significant enough to warrant a takeover bid by a major pharma.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions